The indication for the symptomatic management of knee osteoarthritis with moderate to severe pain is based on a small subgroup of patients in one clinical trial.
None of its components has shown efficacy separately.
Nor does the combination show superiority with regard to placebo in the symptomatic management of knee osteoarthritis.